MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
Globus Medical Cash Conversion Cycle 2011-2026 | GMED
Annual Cash Conversion Cycle Globus Medical
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 319 | 434 | 398 | 383 | 390 | 424 | 315 | 275 | 320 | 303 | 292 | 264 | 297 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 434 | 264 | 340 |
Quarterly Cash Conversion Cycle Globus Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 320 | 304 | 378 | 317 | 341 | 377 | 465 | 420 | 218 | - | 211 | 181 | 407 | - | 395 | 359 | 409 | 55.4 | 397 | 467 | 428 | 66.5 | 417 | 370 | 313 | 63.8 | 328 | 328 | 293 | 60.5 | 277 | 274 | 61.1 | 55.4 | 61.9 | 61 | 55.6 | 49.7 | 51.7 | 53.1 | 53.1 | 53.4 | 58.4 | 60.6 | 55.1 | 49.4 | 53.1 | 53.2 | 50.4 | 48.5 | 51.5 | 50.9 | 48.3 | 48.5 | 50.6 | 26.3 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 467 | 26.3 | 194 |
Cash Conversion Cycle of other stocks in the Medical devices industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
156 | - | - | $ 17.2 B |  USA |
 |
Acutus Medical
AFIB
|
761 | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
271 | - | 3.58 % | $ 2.21 M | USA |
 |
Apollo Endosurgery
APEN
|
156 | - | - | $ 475 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-4.41 | $ 9.57 | 0.1 % | $ 687 M |  Israel |
 |
GenMark Diagnostics, Inc.
GNMK
|
104 | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
251 | $ 22.65 | -0.15 % | $ 3.24 B | USA |
 |
Lianluo Smart Limited
LLIT
|
94.1 | - | 24.59 % | $ 44.8 M |  China |
 |
AxoGen
AXGN
|
195 | $ 33.63 | 0.78 % | $ 1.49 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
299 | - | - | $ 3.31 B | USA |
 |
Apyx Medical Corporation
APYX
|
246 | $ 3.5 | 1.16 % | $ 121 M | USA |
 |
EDAP TMS S.A.
EDAP
|
163 | $ 3.66 | -3.56 % | $ 136 M |  France |
 |
Electromed
ELMD
|
180 | $ 28.9 | -0.41 % | $ 244 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
174 | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
263 | $ 323.76 | 1.47 % | $ 9.13 B | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
118 | $ 97.6 | -0.79 % | $ 144 B | USA |
 |
CONMED Corporation
CNMD
|
218 | $ 43.07 | -2.56 % | $ 1.33 B | USA |
 |
Conformis
CFMS
|
165 | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
227 | $ 54.12 | 3.12 % | $ 8.06 K | USA |
 |
Abbott Laboratories
ABT
|
100 | $ 125.84 | -0.27 % | $ 219 B | USA |
 |
InMode Ltd.
INMD
|
180 | $ 14.47 | 1.47 % | $ 1.15 B | Israel |
 |
CryoLife, Inc.
CRY
|
183 | - | -4.14 % | $ 702 M | USA |
 |
IRIDEX Corporation
IRIX
|
119 | $ 1.16 | -2.94 % | $ 18.7 M | USA |
 |
Cardiovascular Systems
CSII
|
172 | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
404 | - | -10.19 % | $ 1.99 M | USA |
|
LENSAR
LNSR
|
147 | $ 11.6 | -0.6 % | $ 134 M | USA |
 |
Soliton, Inc.
SOLY
|
-67.9 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-227 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
81.2 | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
80.5 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
32.7 | - | - | $ 10.2 M | USA |
 |
Orthofix Medical
OFIX
|
279 | $ 15.77 | -2.65 % | $ 601 M |  Curacao |
 |
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
-21 | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
204 | - | -0.57 % | $ 7.12 M | USA |
 |
Align Technology
ALGN
|
137 | $ 172.23 | 0.97 % | $ 12.9 B | USA |
 |
Accuray Incorporated
ARAY
|
184 | $ 0.89 | -0.47 % | $ 91.5 M | USA |
 |
IRadimed Corporation
IRMD
|
267 | $ 98.81 | -1.19 % | $ 1.25 B | USA |
 |
Avinger
AVGR
|
335 | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
240 | $ 15.06 | -1.63 % | $ 407 M | USA |
 |
FONAR Corporation
FONR
|
234 | $ 18.56 | 0.02 % | $ 122 M | USA |
 |
Sintx Technologies
SINT
|
277 | $ 3.78 | -1.32 % | $ 14.1 M | USA |
 |
Sensus Healthcare
SRTS
|
363 | $ 4.82 | 8.8 % | $ 78.6 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
222 | $ 13.69 | -1.23 % | $ 1.05 B | USA |
 |
Stryker Corporation
SYK
|
364 | $ 369.46 | 0.61 % | $ 141 B | USA |